Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway
Background/Aims: Cardiac hypertrophy is a major predisposing factor for heart failure and sudden cardiac death. Hyperoside (Hyp), a flavonoid isolated from Rhododendron ponticum L., is a primary component of Chinese traditional patent medicines. Numerous studies have shown that Hyp exerts marked ant...
Main Authors: | Xiaofang Wang, Yuan Liu, Lili Xiao, Ling Li, Xiaoyan Zhao, Lulu Yang, Ning Chen, Lu Gao, Jinying Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2018-11-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/495368 |
Similar Items
-
Hyperoside attenuates osteoarthritis progression by targeting PI3K/Akt/NF-κB signaling pathway: In vitro and in vivo studies
by: Yang Yang, et al.
Published: (2022-08-01) -
Cardiac-specific Trim44 knockout in rat attenuates isoproterenol-induced cardiac remodeling via inhibition of AKT/mTOR pathway
by: Xiao-yu Jiang, et al.
Published: (2023-05-01) -
Cardiac-Specific PID1 Overexpression Enhances Pressure Overload-Induced Cardiac Hypertrophy in Mice
by: Yaoqiu Liu, et al.
Published: (2015-03-01) -
Hyperoside exerts potent anticancer activity in skin cancer
by: Yinghui Kong, et al.
Published: (2020-01-01) -
Hyperoside: A Review of Its Structure, Synthesis, Pharmacology, Pharmacokinetics and Toxicity
by: Sijin Xu, et al.
Published: (2022-05-01)